News
StockStory.org on MSN14h
5 Insightful Analyst Questions From CVS Health’s Q1 Earnings CallCVS Health’s first quarter results reflected steady execution across its core businesses, with management highlighting ...
2d
Zacks.com on MSNWill CVS Health's Formulary Move Boost Its Weight Management Program?CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
The health sector makes headlines with global reactions to bird flu impacting chicken exports and the ongoing narrative of ...
KTLA-TV Los Angeles on MSN4d
CVS policy shift may hike cost of popular GLP-1 medsApproximately 15 million Americans are on a GPL-1 or better known as Ozempic, Wegovy and Zepbound but there will be upcoming ...
Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...
Zepbound growth has outpaced Wegovy in recent months, and sales quadrupled to $2.31 billion in the first three months of this year compared to the same period of 2024, while Mounjaro more than ...
The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene ...
6d
Zacks.com on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...
More than 550 community pharmacies have closed across the commonwealth since January 2024, according to the Pennsylvania ...
Shares of weight-loss drugmakers Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) spiked after the American College of Cardiology ...
1don MSN
Louisiana filed several lawsuits accusing pharmaceutical giant CVS of abusing customer information and using its dominant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results